Bone structure assessed with pQCT in prepubertal males with delayed puberty or congenital hypogonadotropic hypogonadism.


Journal

Clinical endocrinology
ISSN: 1365-2265
Titre abrégé: Clin Endocrinol (Oxf)
Pays: England
ID NLM: 0346653

Informations de publication

Date de publication:
07 2021
Historique:
revised: 12 03 2021
received: 12 02 2021
accepted: 14 03 2021
pubmed: 20 3 2021
medline: 28 10 2021
entrez: 19 3 2021
Statut: ppublish

Résumé

Congenital hypogonadotropic hypogonadism (CHH) is associated with impaired bone mineral density in adulthood, whereas the estimates on bone structure in adolescents with CHH has not been previously evaluated. This study describes bone structure in CHH patients and compares it to that in boys with constitutional delay of growth and puberty (CDGP). A cross-sectional study. Peripheral quantitative computed tomography (pQCT) of non-dominant arm and left leg were performed. Volumetric bone mineral density (BMD), bone mineral content, and area in trabecular and cortical bone compartments were evaluated, and bone age-adjusted Z-scores for the bone parameters were determined. The participants with CHH had more advanced bone age and were older, taller and heavier than the CDGP boys, yet they had lower trabecular BMD in distal radius (147.7 mg/mm Five treatment-naïve male patients with CHH exhibited poorer trabecular BMD than untreated males with CDGP. We speculate that timely low-dose sex steroid replacement in CHH males may benefit skeletal health in adulthood.

Identifiants

pubmed: 33738832
doi: 10.1111/cen.14466
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

107-116

Subventions

Organisme : Foundation for Pediatric Research
Organisme : Sigrid Juselius Foundation
Organisme : Helsinki University Hospital Research Funds
Organisme : Academy of Finland

Informations de copyright

© 2021 John Wiley & Sons Ltd.

Références

McCormack SE, Cousminer DL, Chesi A, et al. Association between linear growth and bone accrual in a diverse cohort of children and adolescents. JAMA Pediatr. 2017;171:e171769.
Elhakeem A, Frysz M, Tilling K, Tobias JH, Lawlor DA. Association between age at puberty and bone accrual from 10 to 25 years of age. JAMA Netw Open. 2019;2:e198918.
Almeida M, Laurent MR, Dubois V, et al. Estrogens and androgens in skeletal physiology and pathophysiology. Physiol Rev. 2017;97:135-187.
Gabel L, Nettlefold L, Brasher PM, et al. Reexamining the surfaces of bone in boys and girls during adolescent growth: a 12-year mixed longitudinal pQCT study. J Bone Miner Res. 2015;30:2158-2167.
Kirmani S, Christen D, van Lenthe GH, et al. Bone structure at the distal radius during adolescent growth. J Bone Miner Res. 2009;24:1033-1042.
Vandewalle S, Taes Y, Fiers T, et al. Associations of sex steroids with bone maturation, bone mineral density, bone geometry, and body composition: a cross-sectional study in healthy male adolescents. J Clin Endocrinol Metab. 2014;99:E1272-E1282.
Eriksson AL, Perry JRB, Coviello AD, et al. Genetic determinants of circulating estrogen levels and evidence of a causal effect of estradiol on bone density in men. J Clin Endocrinol Metab. 2018;103:991-1004.
Marshall WA, Tanner JM. Variations in the pattern of pubertal changes in boys. Arch Dis Child. 1970;45:13-23.
Finkelstein JS, Neer RM, Biller BM, Crawford JD, Klibanski A. Osteopenia in men with a history of delayed puberty. N Engl J Med. 1992;326:600-604.
Finkelstein JS, Klibanski A, Neer RM. A longitudinal evaluation of bone mineral density in adult men with histories of delayed puberty. J Clin Endocrinol Metab. 1996;81:1152-1155.
Cousminer DL, Mitchell JA, Chesi A, et al. Genetically determined later puberty impacts lowered bone mineral density in childhood and adulthood. J Bone Miner Res. 2018;33:430-436.
Kuh D, Muthuri SG, Moore A, et al. Pubertal timing and bone phenotype in early old age: findings from a British birth cohort study. Int J Epidemiol. 2016;45:1113-1124.
Finkelstein JS, Klibanski A, Neer RM, Greenspan SL, Rosenthal DI, Crowley WF Jr. Osteoporosis in men with idiopathic hypogonadotropic hypogonadism. Ann Intern Med. 1987;106:354-361.
Antonio L, Caerels S, Jardi F, Delaunay E, Vanderschueren D. Testosterone replacement in congenital hypogonadotropic hypogonadism maintains bone density but has only limited osteoanabolic effects. Andrology. 2019;7:302-306.
Laitinen EM, Hero M, Vaaralahti K, Tommiska J, Raivio T. Bone mineral density, body composition and bone turnover in patients with congenital hypogonadotropic hypogonadism. Int J Androl. 2012;35:534-540.
Finkelstein JS, Lee H, Leder BZ, et al. Gonadal steroid-dependent effects on bone turnover and bone mineral density in men. J Clin Invest. 2016;126:1114-1125.
Young J, Xu C, Papadakis GE, et al. Clinical management of congenital hypogonadotropic hypogonadism. Endocr Rev. 2019;40:669-710.
Varimo T, Huopio H, Kariola L, et al. Letrozole versus testosterone for promotion of endogenous puberty in boys with constitutional delay of growth and puberty: a randomised controlled phase 3 trial. Lancet Child Adolesc Health. 2019;3:109-120.
Kohva E, Varimo T, Huopio H, et al. Anti-mullerian hormone and letrozole levels in boys with constitutional delay of growth and puberty treated with letrozole or testosterone. Hum Reprod. 2020;35:257-264.
Thodberg HH, Kreiborg S, Juul A, Pedersen KD. The BoneXpert method for automated determination of skeletal maturity. IEEE Trans Med Imaging. 2009;28:52-66.
Hansen PF, With TK. Clinical measurements of the testes in boys and men. Acta Med Scand Suppl. 1952;266:457-465.
Ranta S, Viljakainen H, Makipernaa A, Makitie O. Peripheral quantitative computed tomography (pQCT) reveals alterations in the three-dimensional bone structure in children with haemophilia. Haemophilia. 2012;18:955-961.
Rauch F, Schoenau E. Peripheral quantitative computed tomography of the proximal radius in young subjects-new reference data and interpretation of results. J Musculoskelet Neuronal Interact. 2008;8:217-226.
Rauch F, Schoenau E. Peripheral quantitative computed tomography of the distal radius in young subjects - new reference data and interpretation of results. J Musculoskelet Neuronal Interact. 2005;5:119-126.
Roggen I, Roelants M, Sioen I, et al. Pediatric reference values for tibial trabecular bone mineral density and bone geometry parameters using peripheral quantitative computed tomography. Calcif Tissue Int. 2015;96:527-533.
Roggen I, Roelants M, Sioen I, et al. Erratum to: Pediatric reference values for tibial trabecular bone mineral density and bone geometry parameters using peripheral quantitative computed tomography. Calcif Tissue Int. 2015;97:426-427.
Hauta-alus HH, Holmlund-Suila EM, Rita HJ, et al. Season, dietary factors, and physical activity modify 25-hydroxyvitamin D concentration during pregnancy. Eur J Nutr. 2018;57:1369-1379.
Zhu J, Chan YM. Adult consequences of self-limited delayed puberty. Pediatrics. 2017;139(6):e20163177. https://doi.org/10.1542/peds.2016-3177
Bertelloni S, Baroncelli GI, Ferdeghini M, Perri G, Saggese G. Normal volumetric bone mineral density and bone turnover in young men with histories of constitutional delay of puberty. J Clin Endocrinol Metab. 1998;83:4280-4283.
Yap F, Hogler W, Briody J, Moore B, Howman-Giles R, Cowell CT. The skeletal phenotype of men with previous constitutional delay of puberty. J Clin Endocrinol Metab. 2004;89:4306-4311.
Kindblom JM, Lorentzon M, Norjavaara E, et al. Pubertal timing predicts previous fractures and BMD in young adult men: the GOOD study. J Bone Miner Res. 2006;21:790-795.
Guo CY, Jones TH, Eastell R. Treatment of isolated hypogonadotropic hypogonadism effect on bone mineral density and bone turnover. J Clin Endocrinol Metab. 1997;82:658-665.
Behre HM, Kliesch S, Leifke E, Link TM, Nieschlag E. Long-term effect of testosterone therapy on bone mineral density in hypogonadal men. J Clin Endocrinol Metab. 1997;82:2386-2390.
Kalkwarf HJ, Laor T, Bean JA. Fracture risk in children with a forearm injury is associated with volumetric bone density and cortical area (by peripheral QCT) and areal bone density (by DXA). Osteoporos Int. 2011;22:607-616.
Darelid A, Ohlsson C, Rudang R, Kindblom JM, Mellstrom D, Lorentzon M. Trabecular volumetric bone mineral density is associated with previous fracture during childhood and adolescence in males: the GOOD study. J Bone Miner Res. 2010;25:537-544.
Ishizaka K, Suzuki M, Kageyama Y, Kihara K, Yoshida K. Bone mineral density in hypogonadal men remains low after long-term testosterone replacement. Asian J Androl. 2002;4:117-121.
Palmert MR, Dunkel L. Clinical practice. Delayed puberty. N Engl J Med. 2012;366:443-453.
Varimo T. Delayed puberty: etiology, outcome, and interactions with growth. Doctoral dissertation. University of Helsinki, Helsinki, Finland; 2017. http://hdl.handle.net/10138/172664; http://urn.fi/URN:ISBN:978-951-51-2839-3
Sun L, Peng Y, Sharrow AC, et al. FSH directly regulates bone mass. Cell. 2006;125:247-260.
Turner CH, Robling AG. Designing exercise regimens to increase bone strength. Exerc Sport Sci Rev. 2003;31:45-50.
Gabel L, Macdonald HM, Nettlefold L, McKay HA. Physical activity, sedentary time, and bone strength from childhood to early adulthood: a mixed longitudinal HR-pQCT study. J Bone Miner Res. 2017;32:1525-1536.
Handelsman DJ. Sex differences in athletic performance emerge coinciding with the onset of male puberty. Clin Endocrinol (Oxf). 2017;87:68-72.
Miraoui H, Marie PJ. Fibroblast growth factor receptor signaling crosstalk in skeletogenesis. Sci Signal. 2010;3(146):re9.
Counts DR, Pescovitz OH, Barnes KM, et al. Dissociation of adrenarche and gonadarche in precocious puberty and in isolated hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 1987;64:1174-1178.
Jääskeläinen T, Itkonen ST, Lundqvist A, et al. The positive impact of general vitamin D food fortification policy on vitamin D status in a representative adult Finnish population: evidence from an 11-y follow-up based on standardized 25-hydroxyvitamin D data. Am J Clin Nutr. 2017;105:1512-1520.

Auteurs

Tero Varimo (T)

New Children's Hospital, Pediatric Research Center, Helsinki University Hospital, Helsinki, Finland.

Päivi J Miettinen (PJ)

New Children's Hospital, Pediatric Research Center, Helsinki University Hospital, Helsinki, Finland.

Tiina Laine (T)

New Children's Hospital, Pediatric Research Center, Helsinki University Hospital, Helsinki, Finland.

Pia Salonen (P)

Päijät-Häme Central Hospital, Lahti, Finland.

Sirpa Tenhola (S)

Kymenlaakso Central Hospital, Kotka, Finland.

Raimo Voutilainen (R)

Kuopio University Hospital, University of Eastern Finland, Kuopio, Finland.

Hanna Huopio (H)

Kuopio University Hospital, University of Eastern Finland, Kuopio, Finland.

Matti Hero (M)

New Children's Hospital, Pediatric Research Center, Helsinki University Hospital, Helsinki, Finland.

Taneli Raivio (T)

New Children's Hospital, Pediatric Research Center, Helsinki University Hospital, Helsinki, Finland.
Translational Stem Cell Biology and Metabolism Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH